BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36470543)

  • 1. Holistic immunomodulation for small cell lung cancer.
    Leung EL; Fan XX; Huang JM; Huang C; Lin H; Cao YB
    Semin Cancer Biol; 2023 Jan; 88():96-105. PubMed ID: 36470543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Therapeutic Options for Small Cell Lung Cancer.
    Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
    Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is New in Small Cell Lung Cancer.
    Matera R; Chiang A
    Hematol Oncol Clin North Am; 2023 Jun; 37(3):595-607. PubMed ID: 37024387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
    Caliman E; Fancelli S; Petroni G; Gatta Michelet MR; Cosso F; Ottanelli C; Mazzoni F; Voltolini L; Pillozzi S; Antonuzzo L
    Lung Cancer; 2023 Jan; 175():88-100. PubMed ID: 36493578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New Advances in the Treatment for Small Cell Lung Cancer].
    Cui X; Song P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):355-362. PubMed ID: 31196369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective.
    Walia HK; Sharma P; Singh N; Sharma S
    Curr Treat Options Oncol; 2022 Feb; 23(2):268-294. PubMed ID: 35226309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
    Ragavan M; Das M
    Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging the recalcitrant disease-developing molecularly driven treatments for small cell lung cancer.
    Mak DWS; Li S; Minchom A
    Eur J Cancer; 2019 Sep; 119():132-150. PubMed ID: 31445197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The landscape of immune checkpoint inhibitor therapy in advanced lung cancer.
    Wang C; Li J; Zhang Q; Wu J; Xiao Y; Song L; Gong H; Li Y
    BMC Cancer; 2021 Aug; 21(1):968. PubMed ID: 34454455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update 2021: Management of Small Cell Lung Cancer.
    Tariq S; Kim SY; Monteiro de Oliveira Novaes J; Cheng H
    Lung; 2021 Dec; 199(6):579-587. PubMed ID: 34757446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic strategies for recurrent SCLC.
    Moliner L; Zhang B; Lamberti G; Ardizzoni A; Byers LA; Califano R
    Crit Rev Oncol Hematol; 2023 Jun; 186():104017. PubMed ID: 37150311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
    Konala VM; Madhira BR; Ashraf S; Graziano S
    Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Therapy of Small Cell Lung Cancer.
    Schneider BJ; Kalemkerian GP
    Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Highlights of PAPR Inhibitors in Small Cell Lung Cancer].
    Zhang S; Liu J; Yang C; Zhang L; Li S; Bao H; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):806-810. PubMed ID: 32752582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo.
    Liu M; Huang W; Guo Y; Zhou Y; Zhi C; Chen J; Li J; He J; Lian H; Zhou J; Ye X; Hu Y; Hu H; Liu Z; Huang J; Lin L; Cai M; Wang X; Huang J; Zhang Z; Zhu K; Zhao Q; Cao B
    J Leukoc Biol; 2022 Oct; 112(4):901-911. PubMed ID: 35088475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and discussion of the treatment guidelines for small cell lung cancer.
    Zhao H; Ren D; Liu H; Chen J
    Thorac Cancer; 2018 Jul; 9(7):769-774. PubMed ID: 29770597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new hope: the immunotherapy in small cell lung cancer.
    Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
    Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
    Khan P; Siddiqui JA; Maurya SK; Lakshmanan I; Jain M; Ganti AK; Salgia R; Batra SK; Nasser MW
    Semin Cancer Biol; 2022 Aug; 83():57-76. PubMed ID: 33220460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of 
Small Cell Lung Cancer].
    Huang B; Duan Y
    Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):239-244. PubMed ID: 31014443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.
    Leonetti A; Facchinetti F; Minari R; Cortellini A; Rolfo CD; Giovannetti E; Tiseo M
    Cell Oncol (Dordr); 2019 Jun; 42(3):261-273. PubMed ID: 30968324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.